Vimeo: Consulting Media

Thursday, September 5, 2013

Lithium Side Effects in Detail - Drugs.com

Lithium Side Effects in Detail - Drugs.com

For the Consumer

Applies to lithium: oral capsule, oral solution, oral syrup, oral tablet, oral tablet extended release
Along with its needed effects, lithium may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking lithium:
Less common
  • Confusion, poor memory, or lack of awareness
  • fainting
  • fast or slow heartbeat
  • frequent urination
  • increased thirst
  • irregular pulse
  • stiffness of the arms or legs
  • troubled breathing (especially during hard work or exercise)
  • unusual tiredness or weakness
  • weight gain
Rare
  • Blue color and pain in the fingers and toes
  • coldness of the arms and legs
  • dizziness
  • eye pain
  • headache
  • noise in the ears
  • vision problems
Incidence not known
  • Dry, rough skin
  • fast, irregular, pounding, or racing heartbeat or pulse
  • hair loss
  • hoarseness
  • lightheadedness
  • mental depression
  • sensitivity to cold
  • shortness of breath
  • swelling of the feet or lower legs
  • swelling of the neck
  • unusual excitement
Get emergency help immediately if any of the following symptoms of overdose occur while taking lithium:
Symptoms of overdose
  • Blurred vision
  • clumsiness or unsteadiness
  • convulsions (seizures)
  • diarrhea
  • drowsiness
  • increase in the amount of urine
  • lack of coordination
  • loss of appetite
  • muscle weakness
  • nausea or vomiting
  • ringing in the ears
  • slurred speech
  • trembling (severe)
Some side effects of lithium may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common
  • Acne or skin rash
  • bloated feeling or pressure in the stomach
  • muscle twitching (slight)

For Healthcare Professionals

Applies to lithium: compounding powder, oral capsule, oral syrup, oral tablet, oral tablet extended release
Nervous system
The hand tremor associated with lithium therapy is usually a fine rapid intentional tremor. Coarsening of the tremor or occurrence of tremor in a new part of the body may suggest lithium toxicity.

A wide variety of other nervous system effects have been reported and include ataxia, dysarthria, hyperreflexia, other movement disorders, EEG changes, blackouts, stupor, coma, central incontinence, sleep disturbances, dizziness, vertigo, pseudotumor cerebri, seizures, and worsening of organic brain syndrome.

One study (n=34) has concluded that chronic maintenance treatment with lithium affects the peripheral nerves even if the impairment rarely leads to discontinuation of therapy. This study suggests that monitoring of electroneuronographic results could be useful for the early detection of neurotoxicity of lithium.
Nervous system side effects most commonly have included nervous system effects include tremor, lethargy, lassitude, and muscle weakness. Headache, decreased concentration and confusion also have been reported less frequently. Most of these effects resolve during continuing therapy.
Gastrointestinal
Gastrointestinal side effects including nausea, vomiting, diarrhea, anorexia, abdominal pain, and dry mouth have been reported frequently.
Taking lithium with meals or dividing doses may ameliorate some of the gastrointestinal effects of lithium.

Thursday, August 22, 2013

MMWR News Synopsis for August 22, 2013

MMWR News Synopsis for August 22, 2013

MMWR – Morbidity and Mortality Weekly Report

MMWR News Synopsis for August, 22, 2013

1. Occupational Highway Transportation Deaths Among Workers Aged ≥55 Years — United States, 2003–2010
In light of high rates of fatal motor vehicle crashes among older workers, employer policies and programs (e.g., flexible scheduling, trip planning, information on the effects of medications on driving, and health screenings) can help older workers drive more safely on the job.
2. Japanese Encephalitis Surveillance and Immunization — Asia and the Western Pacific, 2012
Japanese encephalitis (JE) is an important public health problem, but this serious disease is preventable by vaccination. Safe and effective vaccines are available, and prequalification by the World Health Organization is pending.
3. Polio Field Census Conducted Among Underserved Populations — Nigeria, 2012–2013
Through NSTOP, highly educated and culturally competent Nigerian public health professionals are expanding access to previously unreached settlements, thus improving the polio vaccination coverage in Northern Nigeria and contributing to the end of polio.
4. Investigational Drug for the Treatment of Free-Living Ameba Infections Now Available Directly from CDC
CDC has a potentially life-saving drug available for physicians to use in the treatment of free-living ameba infections. Infections caused by free-living amebae (FLA), which includes the “brain-eating ameba” Naegleria fowleri, are severe and life-threatening and effective treatment is lacking. Miltefosine has shown activity against FLA in the laboratory.

5. Notes from the Field

Eye Injuries Sustained at a Foam Party — Collier County, Florida 2012
Read More>>

Thursday, August 15, 2013

DuPage Sheriff to lead new search for John Spira, missing since 2007 | Suburban Life Media

DuPage Sheriff to lead new search for John Spira, missing since 2007 | Suburban Life Media

Florida Airline Fuel Supply Company and Its Owner Indicted for Role in Scheme to Defraud Illinois-Based Ryan International Airlines

Florida Airline Fuel Supply Company and Its Owner Indicted for Role in Scheme to Defraud Illinois-Based Ryan International Airlines
WASHINGTON — A Florida-based airline fuel supply service company and its former owner and operator were indicted yesterday on charges of participating in a scheme to defraud Illinois-based Ryan International Airlines, the Department of Justice announced.
A federal grand jury in the U.S. District Court for the Southern District of Florida in West Palm Beach, Fla., returned an indictment against Sean E. Wagner and his company Aviation Fuel International Inc. (AFI), an airline fuel supply company.  The indictment alleges that Wagner and AFI participated in a conspiracy to defraud Ryan, a charter airline company based in Rockford, Ill., by making kickback payments to Wayne Kepple, a former vice president of ground operations for Ryan, in exchange for awarding business to AFI. Wagner was arrested on July 19, 2013, in Weston, Fla., on a one-count criminal complaint in connection with these charges.
Ryan provided air passenger and cargo services for corporations, private individuals and the U.S. government – including the U.S. Department of Defense and the U.S. Department of Homeland Security.
The indictment alleges, among other things, that from at least as early as December 2005 through at least August 2009, Wagner, AFI and others made kickback payments totaling more than $200,000, in the form of checks, wire transfers, cash and gift cards, to Kepple while working at Ryan.
“The conspirators traded contracts for kickbacks and took affirmative steps to hide their illegal scheme, including wiring payments to personal bank accounts and making secret cash payments,” said Bill Baer, Assistant Attorney General in charge of the Department of Justice’s Antitrust Division.  “The division will continue to aggressively prosecute companies and individuals that seek to defraud the government and U.S. taxpayers by thwarting the competitive process.”
Wagner and AFI are charged with one count of conspiracy to commit wire fraud and honest services fraud, as well as two counts of wire fraud and two counts of mail fraud.  Each count carries a maximum sentence of 20 years in prison and a $250,000 criminal fine for individuals and a $500,000 criminal fine for corporations.  The maximum fine may be increased to twice the gain derived from the crime or twice the loss suffered by the victims of the crime, if either amount is greater than the statutory maximum fine.
As a result of this ongoing investigation, four individuals have pleaded guilty to date. Three of the individuals have been ordered to serve sentences ranging from 16 to 24 months in prison and to pay more than $220,000 in restitution.  The fourth individual, Kepple, pleaded guilty and is currently awaiting sentencing.
The charges are the result of an investigation being conducted by the Antitrust Division’s National Criminal Enforcement Section and the U.S. Department of Defense’s Office of Inspector General with assistance from the U.S. Attorney’s Office for the Southern District of Florida.  Anyone with information concerning anticompetitive conduct in the airline charter services industry is urged to call the Antitrust Division’s National Criminal Enforcement Section at 202-307-6694 or visit www.justice.gov/atr/contact/newcase.htm.

Wednesday, August 14, 2013

Warning Letters

Warning Letters from the Federal Drug Administration
Types of Warning Letters on the FDA Website